• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传变异与肝细胞癌相关:个性化医疗向前迈进了一步。

Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward.

机构信息

Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

出版信息

Am J Gastroenterol. 2018 Oct;113(10):1435-1436. doi: 10.1038/s41395-018-0260-z. Epub 2018 Oct 5.

DOI:10.1038/s41395-018-0260-z
PMID:30291316
Abstract

: There are strong associations between candidate genetic polymorphisms associated with intrahepatocyte lipid droplet accumulation and the development of cirrhosis, via a common sequence in which lipid accumulation is followed by chronic inflammatory injury and fibrogenesis. Hepatocellular carcinoma (HCC) has also been linked to genetic polymorphisms associated with intracellular lipid trafficking, although, as shown in the present study, not all the candidate polymorphisms implicated in fibrogenesis are also tied to HCC. Genetic analysis may identify at-risk persons who would most benefit from modifying life-style factors linked to cirrhosis and HCC, and also persons most likely to benefit from HCC surveillance.

摘要

: 与肝细胞内脂滴蓄积相关的候选基因多态性与肝硬化的发生之间存在密切关联,其发生机制涉及一个共同的序列,即脂滴蓄积后发生慢性炎症损伤和纤维化。肝细胞癌 (HCC) 也与与细胞内脂质转运相关的基因多态性相关,尽管如本研究所示,并非所有与纤维化相关的候选多态性也与 HCC 相关。遗传分析可能会识别出处于危险中的人群,这些人最有可能从与肝硬化和 HCC 相关的生活方式因素的改变中受益,也最有可能从 HCC 监测中受益。

相似文献

1
Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward.遗传变异与肝细胞癌相关:个性化医疗向前迈进了一步。
Am J Gastroenterol. 2018 Oct;113(10):1435-1436. doi: 10.1038/s41395-018-0260-z. Epub 2018 Oct 5.
2
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.全基因组关联研究鉴定出 TLL1 变异与丙型肝炎病毒感染清除后肝细胞癌发展相关。
Gastroenterology. 2017 May;152(6):1383-1394. doi: 10.1053/j.gastro.2017.01.041. Epub 2017 Feb 3.
3
Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.人类白细胞抗原DQ基因多态性及其与乙型肝炎病毒突变的相互作用对病毒持续存在、肝硬化和肝细胞癌风险的影响。
Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2.
4
Association of Interleukin-8 Gene Polymorphisms and Expression with Hepatocellular Carcinoma in Egyptian Patients with Liver Cirrhosis.白细胞介素-8基因多态性及表达与埃及肝硬化患者肝细胞癌的关联
Egypt J Immunol. 2017 Jan;24(1):143-152.
5
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.单核苷酸多态性与肝硬化肝细胞癌的风险。
J Hepatol. 2012 Sep;57(3):663-74. doi: 10.1016/j.jhep.2012.02.035. Epub 2012 May 16.
6
Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population.表皮生长因子rs4444903的基因多态性影响中国汉族人群中丙型肝炎病毒相关肝硬化和肝细胞癌的易感性。
Clin Lab. 2017 Apr 1;63(4):845-850. doi: 10.7754/Clin.Lab.2016.161203.
7
Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.PD1 和 TIM3 的遗传变异与慢性乙型肝炎病毒感染患者肝硬化和 HCC 的发展呈差异性和交互性相关。
Infect Genet Evol. 2013 Mar;14:240-6. doi: 10.1016/j.meegid.2012.12.008. Epub 2013 Jan 2.
8
PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.载脂蛋白基因 PNPLA3 rs738409C/G 多态性与肝硬化:与肝病病因及肝细胞癌发生的关系。
Liver Int. 2011 Sep;31(8):1137-43. doi: 10.1111/j.1478-3231.2011.02534.x. Epub 2011 Apr 19.
9
Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.细胞因子基因变异对肝硬化患者肝细胞癌的预测和预后的影响。
J Hepatol. 2014 Aug;61(2):342-50. doi: 10.1016/j.jhep.2014.04.011. Epub 2014 Apr 18.
10
[Hepatocellular carcinoma].[肝细胞癌]
Internist (Berl). 2017 May;58(5):469-479. doi: 10.1007/s00108-017-0226-z.

引用本文的文献

1
NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling.NQO1 通过放大 ERK-NRF2 信号促进肝癌的侵袭表型。
Cancer Sci. 2021 Feb;112(2):641-654. doi: 10.1111/cas.14744. Epub 2020 Dec 13.
2
Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.癌症纳米技术:增强肿瘤细胞对化疗的反应以治疗肝细胞癌
Asian J Pharm Sci. 2019 Nov;14(6):581-594. doi: 10.1016/j.ajps.2019.04.005. Epub 2019 Jun 12.